COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 1715: Articles 17141-17150  | Next

Understanding and Addressing Vaccine Hesitancy in the Context of COVID-19: Development of a Digital intervention
Knight, H., Jia, R., Ayling, K., Bradbury, K., Baker, K., Chalder, T., Morling, J. R., Durrant, L., Avery, T., Ball, J., Barker, C., Bennett, R., McKeever, T., vedhara, k.
10.1101/2021.03.24.21254124 — Posted: 2021-03-26
Relationship between teaching modality and COVID-19, well-being, and teaching satisfaction (Campus & Corona): a cohort study among students in higher education
Fretheim, A., Helleve, A., Loyland, B., Sandbekken, I. H., Flato, M., Telle, K., Watle, S. S. V., Schjoll, A., Helseth, S., Jamtvedt, G., Hart, R. K.
10.1101/2021.03.26.21254388 — Posted: 2021-03-26
COVID-19 Vaccine's Gender Paradox
Galasso, V., Profeta, P., Foucault, M., Pons, V.
10.1101/2021.03.26.21254380 — Posted: 2021-03-26
Public Opinion about the UK Government during COVID-19 and Implications for Public Health: A Topic Modelling Analysis of Open-Ended Survey Response Data
Wright, L., Burton, A., McKinlay, A., Steptoe, A., Fancourt, D.
10.1101/2021.03.24.21254094 — Posted: 2021-03-26
Acute and longer-term psychological distress associated with testing positive for COVID-19: longitudinal evidence from a population-based study of US adults
Daly, M., Robinson, E.
10.1101/2021.03.25.21254326 — Posted: 2021-03-26
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period
Anda, E. E., Braaten, T., Borch, K. B., Nost, T. H., Chen, S. L. F., Lukic, M., Lund, E., Forland, F., Leon, D., Winje, B. A., Kran, A.-M. B., Kalager, M., Johansen, F. L., Sandanger, T. M.
10.1101/2021.03.23.21253730 — Posted: 2021-03-26
COVID-19 Vaccination Prioritization Based on Cardiovascular Risk Factors and Number-Needed-to-Vaccinate to Prevent Death
Leong, D. P., Banerjee, A., Yusuf, S.
10.1101/2021.03.24.21254227 — Posted: 2021-03-26
Wastewater monitoring outperforms case numbers as a tool to track COVID-19 incidence dynamics when test positivity rates are high
Fernandez-Cassi, X., Scheidegger, A., Baenziger, C., Cariti, F., Tunas Corzon, A., Ganesanandamoorthy, P., Lemaitre, J. C., Ort, C., Julian, T. R., Kohn, T.
10.1101/2021.03.25.21254344 — Posted: 2021-03-26
Geographically-targeted COVID-19 vaccination is more equitable than age-based thresholds alone
Wrigley-Field, E., Kiang, M. V., Riley, A. R., Barbieri, M., Chen, Y.-H., Duchowny, K. A., Matthay, E. C., Van Riper, D., Jegathesan, K., Bibbins-Domingo, K., Leider, J. P.
10.1101/2021.03.25.21254272 — Posted: 2021-03-26
Dynamic Data-Driven Algorithm to Predict the Cumulative COVID-19 Infected Cases Using Susceptible-Infected-Susceptible Model
Anand, A., Kumar, S., Ghosh, P.
10.1101/2021.03.24.21253599 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).